AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|AAPL297.11+2.81 (+0.95%) ▲|ABBV233.23-1.53 (-0.65%) ▼|ABT91.02+0.49 (+0.54%) ▲|ACN128.32+1.31 (+1.03%) ▲|ADBE200.14+2.71 (+1.37%) ▲|AMAT587.97+2.09 (+0.36%) ▲|AMD518.31-1.54 (-0.30%) ▼|AMGN351.38+4.37 (+1.26%) ▲|AMT174.81-4.57 (-2.55%) ▼|AMZN241.29+7.18 (+3.07%) ▲|AVGO385.58+5.43 (+1.43%) ▲|AXP342.40+4.62 (+1.37%) ▲|BA221.13+4.42 (+2.04%) ▲|BAC57.72-0.20 (-0.34%) ▼|BKNG183.47+14.53 (+8.60%) ▲|BLK984.16-31.17 (-3.07%) ▼|BMY55.29-0.25 (-0.44%) ▼|BNY145.71-1.58 (-1.07%) ▼|BRK-B496.34+3.53 (+0.72%) ▲|C144.26-0.71 (-0.49%) ▼|CAT1,000.22+15.98 (+1.62%) ▲|CL92.42+0.99 (+1.08%) ▲|CMCSA22.72-0.08 (-0.35%) ▼|COF202.07+4.26 (+2.15%) ▲|COP106.34-3.63 (-3.30%) ▼|COST962.15+4.47 (+0.47%) ▲|CRM155.16+1.74 (+1.13%) ▲|CSCO122.07+0.92 (+0.76%) ▲|CVS100.14-1.43 (-1.41%) ▼|CVX170.95-5.03 (-2.86%) ▼|DE607.33+15.39 (+2.60%) ▲|DHR188.00+9.03 (+5.05%) ▲|DIS103.90+0.37 (+0.36%) ▲|DUK125.22+0.17 (+0.14%) ▲|EMR143.84+0.70 (+0.49%) ▲|FDX312.67-4.57 (-1.44%) ▼|GD345.92-4.43 (-1.26%) ▼|GE367.75+11.28 (+3.16%) ▲|GEV1,061.97+26.99 (+2.61%) ▲|GILD125.53+0.48 (+0.38%) ▲|GM79.72+0.77 (+0.98%) ▲|GOOG351.73+5.65 (+1.63%) ▲|GOOGL352.40+6.31 (+1.82%) ▲|GS1,081.71-12.73 (-1.16%) ▼|HD338.99+14.54 (+4.48%) ▲|HON228.52+6.15 (+2.76%) ▲|IBM263.03-1.91 (-0.72%) ▼|INTC135.30+3.02 (+2.28%) ▲|INTU266.49+8.44 (+3.27%) ▲|ISRG404.56+1.38 (+0.34%) ▲|JNJ239.90+0.82 (+0.34%) ▲|JPM332.88-1.27 (-0.38%) ▼|KO81.26+0.95 (+1.18%) ▲|LIN520.77+8.51 (+1.66%) ▲|LLY1,106.33-0.76 (-0.07%) ▼|LMT496.16-7.51 (-1.49%) ▼|LOW221.27+7.73 (+3.62%) ▲|LRCX370.22-1.11 (-0.30%) ▼|MA496.11+8.04 (+1.65%) ▲|MCD273.96+2.30 (+0.85%) ▲|MDLZ62.20+1.14 (+1.87%) ▲|MDT80.73+0.10 (+0.12%) ▲|META565.67+3.47 (+0.62%) ▲|MMM167.96+6.12 (+3.78%) ▲|MO71.51-0.10 (-0.14%) ▼|MRK119.57-0.03 (-0.03%) ▼|MS222.58-3.45 (-1.53%) ▼|MSFT374.78+0.84 (+0.22%) ▲|MU1,044.62-7.15 (-0.68%) ▼|NEE86.61+0.18 (+0.21%) ▲|NFLX72.42-0.40 (-0.55%) ▼|NKE41.88-0.51 (-1.19%) ▼|NOW95.66-0.28 (-0.29%) ▼|NVDA201.15+1.15 (+0.58%) ▲|ORCL160.23-4.93 (-2.99%) ▼|PEP143.07+1.02 (+0.72%) ▲|PFE24.34-0.38 (-1.52%) ▼|PG152.76+1.90 (+1.26%) ▲|PLTR115.34-1.37 (-1.17%) ▼|PM177.59-1.10 (-0.62%) ▼|QCOM199.00-5.13 (-2.51%) ▼|RTX185.80-0.59 (-0.32%) ▼|SBUX103.14+2.09 (+2.07%) ▲|SCHW91.77-1.41 (-1.51%) ▼|SO94.79-0.14 (-0.15%) ▼|SPG218.26+1.52 (+0.70%) ▲|T22.52-0.30 (-1.29%) ▼|TMO487.55+18.20 (+3.88%) ▲|TMUS183.52-1.05 (-0.57%) ▼|TSLA382.92+1.31 (+0.34%) ▲|TXN305.33+0.97 (+0.32%) ▲|UBER74.72+5.05 (+7.25%) ▲|UNH403.79-5.47 (-1.34%) ▼|UNP262.44+3.83 (+1.48%) ▲|UPS105.65-0.18 (-0.17%) ▼|USB60.10+0.05 (+0.08%) ▲|V332.54+4.06 (+1.23%) ▲|VZ45.84-0.90 (-1.92%) ▼|WFC83.96-0.17 (-0.20%) ▼|WMT119.78+0.36 (+0.30%) ▲|XOM135.81-3.92 (-2.81%) ▼|
24.7 C
New York
Wednesday, June 24, 2026

Tag: treatments

Weekly Recap: 11 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including advances in sleep apnea treatments, fall detection for seniors...

Concordia Shanghai Breaks Ground on Visionary New Rittmann Center

State-of-the-art facility will transform student life through the arts, athletics, and wellness. SHANGHAI, June 13, 2025 /PRNewswire/ -- Concordia International School Shanghai is set to...

BioArctic to initiate next cohorts in exidavnemab Phase 2a study after positive safety review

STOCKHOLM, June 13, 2025 /PRNewswire/ -- BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase...

Meta’s New Toy: Eavesdropping Made Easy

Meta’s AI platform’s become the Wild West of oversharing, folks. Users are airing details they probably shouldn’t, and it seems nobody’s clued them in...

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025

HAMPTON, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of life at 76 weeks, 7 months after the completion of dosing with barzolvolimab in chronic spontaneous urticaria (CSU), an immune-related condition driven by mast cell activation. Barzolvolimab specifically targets mast cells by binding the receptor tyrosine kinase KIT with high specificity and potently inhibiting its activity, which is required for mast cell function and survival.

4 Emerging Graft versus Host Disease Therapies That Could Change the Treatment Landscape | DelveInsight

Key companies, such as CSL Behring, Equillium, Biocon, and medac, are advancing their assets through late-stage graft versus host disease clinical trials, driving innovation...

Cancer Pain Market Set to Transform by 2034 Due to Launch of Breakthrough Therapies | DelveInsight

According to DelveInsight's analysis, the growth of the cancer pain market is expected to be mainly driven by increasing incidence and advances in disease...

Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer

RESEARCH TRIANGLE PARK, N.C., June 12, 2025 /PRNewswire/ -- Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder...

CUNARD’S NEWLY REFRESHED QUEEN ELIZABETH ARRIVES TO SEATTLE FOR THE FIRST TIME IN A SPECIAL SERIES OF VOYAGES TO ALASKA

Alaskan voyages mark the beginning of Queen Elizabeth's North American residency as she prepares for her highly anticipated maiden season of Caribbean voyages starting...

Specialised Therapeutics Expands Partnership with Incyte to Include Two Additional Therapies for Hard-to-Treat Conditions

SINGAPORE, June 12, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agreement...

Parent Project Muscular Dystrophy Announces Children’s Hospital of Philadelphia as Certified Duchenne Care Center, Recipient of Inaugural Clinical Research Designation

WASHINGTON, June 12, 2025 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), is...

Bay Area Lyme Foundation Announces National Winner of the 2025 Emerging Leader Award to Develop a Much-Needed Rapid, Low-Cost, Easy-to-Use Lyme Disease Test

Winner Chao Wang of Arizona State University will receive $150,000 to evaluate a unique diagnostic that uses gold nanoparticles and has been proven in other infectious diseases
Winner Chao Wang of Arizona State University will receive $150,000 to evaluate a unique diagnostic that uses gold nanoparticles and has been proven in other infectious diseases

As Public Cancer Funding Wavers, Oncology’s Brightest Breakthroughs Are Coming From Industry

Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /CNW/ -- Equity Insider News Commentary – The 2025 ASCO...

Mosquito Joe® Urges Prevention as Summer Mosquito Threat Looms

Leading Pest Control Company Encourages Action Ahead of National Mosquito Control Awareness Week VIRGINIA BEACH, Va., June 12, 2025 /PRNewswire/ -- As the nation prepares...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTreatments